Thrombin inhibition profiles in healthy individuals and thrombophilic patients.

Abstract excerpt

Inhibition of thrombin by endogenous inhibitors plays a central role in the spatiotemporal control of clot formation. A failure to adequately inactivate thrombin such as in antithrombin deficiency generates a strong prothrombotic phenotype. To study if and to what extent delayed thrombin inactivation rates beyond antithrombin deficiency contribute to the prothrombotic phenotype we measured thrombin inhibition...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Thrombin
• Share to Antibodies, Antiphospholipid